ARTICLE | Clinical News
AmBisome liposomal amphotericin B: NXTR began enrolling patients in a compassionate use protocol of AmBisome
March 11, 1996 8:00 AM UTC
NeXstar Pharmaceuticals Inc. (NXTR), Boulder, Colo. Product: AmBisome liposomal amphotericin B Indication: Invasive fungal infections Status: NXTR began enrolling patients in a compassionate use prot...